Your institution may have access to this item. Find your institution then sign in to continue.
Title
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.
Authors
Feig, P U; Shah, S; Hermanowski-Vosatka, A; Plotkin, D; Springer, M S; Donahue, S; Thach, C; Klein, E J; Lai, E; Kaufman, K D
Abstract
We examined the effects of the 11β-hydroxysteroid dehydrogenase type 1 (HSD1) inhibitor, MK-0916, on the multiple components of the metabolic syndrome (MetS) in patients with type 2 diabetes (T2DM) and MetS.